What Have Meds Taught Us?
...And the Four Psychological Conditions That Are Lifelong Disorders
By John Preston - A snapshot of the advancements, setbacks, and future prospects for the world of medication (and why psychotherapy is still just as important as ever).
Daily Blog
VIDEO: Why Anticipating Relapse Is Our Best Defense Against It
How to Mobilize the Client’s Support System
It’s always cause for celebration when depressed clients nears the finish line of treatment, feeling energized, empowered, and more content with their life. But it’s one thing to get people back on their feet from a depressive episode; it’s another to prevent recurrences down the road.
Daily Blog
Then, Now & Tomorrow
Oral Histories of Psychotherapy 1978-2017
A group of innovators and leaders look back over different realms of therapeutic practice and offer their view of the eureka moments, the mistakes and misdirections, and the inevitable trial-and-error processes that have shaped the evolution of different specialty areas within the field.
- Trauma: Retreats and Advances BESSEL VAN DER KOLK
- Couples: In Search of a Safe Haven JOHN GOTTMAN
- Systems Therapy: The Art of Creating Uncertainty SALVADOR MINUCHIN
- Family Violence: Out of the Shadows MARY JO BARRETT
- Psychopharmacology: The Jury Is Still Out JOHN PRESTON
- Race Matters: How Far Have We Come? KENNETH HARDY
- Neuroscience and Therapy: The Craft of Rewiring the Brain DANIEL SIEGEL
Magazine Article
VIDEO: What Therapists Need to Know about the Research on Meds
Helping Clients Recognize their Treatment Options
When it comes to treating depression, neuropsychologist John Preston, author of Clinical Psychopharmacology Made Ridiculously Simple, says that psychoactive medication is only one alternative and often not the most effective. In addition to his integrative approach—which includes exercise, combating social withdrawal, family involvement, and possibly meds—he’s always on the lookout for toxic relationship issues in the client’s life.
Daily Blog
SSRIs in Perspective
Have They Lived up to Their Promise?
After wading through the controversies and contradictions in the research literature on SSRIs, a critic of Big Pharma explains why he thinks these drugs may have gotten a bad rap.
Magazine Article
In Consultation
It’s More Complicated Than That: Probing the complexities of the antidepressants debate
The recent spate of negative research findings and unfavorable media coverage of antidepressant drugs have obscured some important clinical issues.
Magazine Article
Page 1 of 1 (6 Items)
Page 1 of 1 (0 Items)
What Have Meds Taught Us?
...And the Four Psychological Conditions That Are Lifelong Disorders
By John Preston - A snapshot of the advancements, setbacks, and future prospects for the world of medication (and why psychotherapy is still just as important as ever).
Daily Blog
VIDEO: Why Anticipating Relapse Is Our Best Defense Against It
How to Mobilize the Client’s Support System
It’s always cause for celebration when depressed clients nears the finish line of treatment, feeling energized, empowered, and more content with their life. But it’s one thing to get people back on their feet from a depressive episode; it’s another to prevent recurrences down the road.
Daily Blog
VIDEO: What Therapists Need to Know about the Research on Meds
Helping Clients Recognize their Treatment Options
When it comes to treating depression, neuropsychologist John Preston, author of Clinical Psychopharmacology Made Ridiculously Simple, says that psychoactive medication is only one alternative and often not the most effective. In addition to his integrative approach—which includes exercise, combating social withdrawal, family involvement, and possibly meds—he’s always on the lookout for toxic relationship issues in the client’s life.
Daily Blog
Page 1 of 1 (3 Items)
Then, Now & Tomorrow
Oral Histories of Psychotherapy 1978-2017
A group of innovators and leaders look back over different realms of therapeutic practice and offer their view of the eureka moments, the mistakes and misdirections, and the inevitable trial-and-error processes that have shaped the evolution of different specialty areas within the field.
- Trauma: Retreats and Advances BESSEL VAN DER KOLK
- Couples: In Search of a Safe Haven JOHN GOTTMAN
- Systems Therapy: The Art of Creating Uncertainty SALVADOR MINUCHIN
- Family Violence: Out of the Shadows MARY JO BARRETT
- Psychopharmacology: The Jury Is Still Out JOHN PRESTON
- Race Matters: How Far Have We Come? KENNETH HARDY
- Neuroscience and Therapy: The Craft of Rewiring the Brain DANIEL SIEGEL
Magazine Article
SSRIs in Perspective
Have They Lived up to Their Promise?
After wading through the controversies and contradictions in the research literature on SSRIs, a critic of Big Pharma explains why he thinks these drugs may have gotten a bad rap.
Magazine Article
In Consultation
It’s More Complicated Than That: Probing the complexities of the antidepressants debate
The recent spate of negative research findings and unfavorable media coverage of antidepressant drugs have obscured some important clinical issues.
Magazine Article
Page 1 of 1 (3 Items)
John Preston, Psy.D., ABPP, is a professor with Alliant International University (California School of Professional Psychology), Sacramento. He has also taught at UC Davis, School of Medicine. He is the author/co-author of 21 books on various topics including depression, psychotherapy, psychopharmacology, borderline disorders, bipolar disorder, and post-traumatic stress disorder. He is the author of Drugs in Psychiatry chapter in the Encyclopedia Americana as well as Integrative Treatment for Borderline Personality Disorder: Effective, Symptom-Focused Techniques, Simplified for Private Practice. Dr. Preston is the recipient of the Mental Health Association’s President’s Award for contributions to the mental health community and the California Psychological Association’s “Distinguished Contributions to Psychology” award. He has lectured in the United States, Canada, Europe, Africa, and Russia.
Speaker Disclosures: Financial: John D. Preston is an author for numerous publishers including Impact Publishers, New Harbinger Publications, and Abingdon Press. He receives a speaking honorarium from PESI, Inc.
Non-Financial: John D. Preston has no relevant non-financial relationship to disclose.
Speaker Disclosures: Financial: John D. Preston is an author for numerous publishers including Impact Publishers, New Harbinger Publications, and Abingdon Press. He receives a speaking honorarium from PESI, Inc.
Non-Financial: John D. Preston has no relevant non-financial relationship to disclose.
